» Authors » Alessandra Brendolan

Alessandra Brendolan

Explore the profile of Alessandra Brendolan including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 75
Citations 804
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Soranno D, Awdishu L, Bagshaw S, Basile D, Bell S, Bihorac A, et al.
Kidney Int . 2025 Jan; PMID: 39848406
Sex differences exist in acute kidney injury (AKI), and the role that sex and gender play along the AKI care continuum remains unclear. The 33rd Acute Disease Quality Initiative meeting...
2.
Ferrari F, Milla P, Sartori M, Zanza C, Tesauro M, Longhitano Y, et al.
Clin Pharmacokinet . 2024 Aug; 63(8):1167-1176. PMID: 39102092
Background And Objective: Renal replacement therapy (RRT) plays a critical role in antimicrobial removal, particularly for low-molecular-weight drugs with low plasma protein binding, low distribution volume and hydrophilicity. Medium cut-off...
3.
Lorenzin A, De Cal M, Perin N, Morisi N, Brendolan A, Lentini P, et al.
Blood Purif . 2024 Jul; 53(10):773-780. PMID: 39068927
Introduction: Enkephalins, endogenous opioid peptides, are involved in the regulation of renal function. One derived molecule, proenkephalin A, also known as penKid, has been demonstrated to be a reliable biomarker...
4.
Caprara C, Virzi G, Chieregato K, Marchionna N, Corradi V, Brendolan A, et al.
J Clin Med . 2024 Apr; 13(7). PMID: 38610912
: Patients with end-stage kidney disease (ESKD) have altered immunity. Patients on hemodialysis (HD) present a coexistence of immunodeficiency and activation of the immune system. We evaluated the immunophenotypic profile...
5.
Pavan P, Lorenzin A, Chiementin L, Perin N, De Cal M, Brendolan A, et al.
Blood Purif . 2024 Mar; 53(8):613-623. PMID: 38493768
Introduction: Per- and polyfluoroalkyl substances (PFAS) are known water pollutants leading to potential public health consequences. High blood levels of PFAS have been associated with several pathological conditions including testicular...
6.
Ramirez-Guerrero G, Ronco C, Lorenzin A, Brendolan A, Sgarabotto L, Zanella M, et al.
Heart Fail Rev . 2024 Jan; 29(3):615-630. PMID: 38289525
Acute decompensated heart failure and fluid overload are the most common causes of hospitalization in heart failure patients, and often, they contribute to disease progression. Initial treatment encompasses intravenous diuretics...
7.
Reis T, Sgarabotto L, Brendolan A, Lorenzin A, Corradi V, Marchionna N, et al.
Cardiorenal Med . 2023 May; 13(1):176-183. PMID: 37231837
Introduction: Fluid overload and congestion are common features in patients with heart failure and are associated with negative clinical outcomes. Therapies for these conditions are diuretic-centered but frequently fail to...
8.
Lorenzin A, Sgarabotto L, Bacci M, Elmi A, Ventrella D, Aniballi C, et al.
Cardiorenal Med . 2023 Mar; 13(1):167-175. PMID: 36977396
Introduction: We have recently developed a new miniaturized device for extracorporeal ultrafiltration (UF) to be used in patients with fluid overload: Artificial Diuresis-1 (AD1) (Medica S.p.A., Medolla, Italy). The device...
9.
Sgarabotto L, Kazory A, Brendolan A, Di Lullo L, Zanella M, Ronco C
Cardiorenal Med . 2023 Feb; 13(1):46-55. PMID: 36787707
Introduction: Fluid overload has been associated with untoward outcomes in a variety of clinical settings. Isolated extracorporeal ultrafiltration (UF) allows for mechanical extraction of excess fluid and optimization of volume...
10.
Ronco C, Brendolan A, Sgarabotto L
Cardiorenal Med . 2022 Dec; 13(1):34-37. PMID: 36521449
Fluid overload in different acute or chronic clinical settings results in unfavorable outcomes. The use of restrictive strategies for fluid control or the use of diuretics is frequently ineffective and...